BIO CEO & Investor Conference 2025

Location: New York, NY

Date:

Event description:

Join Novotech at the BIO CEO & Investor Conference on February 10–11, in New York, NY. This event provides a platform for institutional investors, industry analysts, and senior executives to discuss opportunities in biotechnology, including private and publicly traded companies. 

Why meet with Novotech?  

  • Early Phase Expertise: Novotech has conducted over 350 healthy volunteer and early-phase studies across Asia Pacific, North America, and Europe.
  • Equity Funding Model: Discuss our funding support model (<$1M USD) designed to "prime" additional capital required to bring development programs to clinic.
  • Comprehensive Consulting Services: Novotech provides global drug development planning, regulatory interaction support with FDA/EMA, and "lab to launch" program development. 

Steven Roan, Associate Business Development Director, will be available to discuss Novotech’s tailored solutions and expertise. 

Connect with Steven Roan on the partnering platform 2025 BIO CEO & Investor Conference 

This event has concluded

Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.

Have a question or want to continue the conversation?

Talk to a Clinical Development Expert

Meet Our Team

Novotech

Steven Roan

Novotech
Associate Business Development Director

Plus experts from our China, Drug Development, and global Commercial teams.